Literature DB >> 19648187

Americans' attitudes toward psychiatric medications: 1998-2006.

Ramin Mojtabai1.   

Abstract

OBJECTIVES: This study examined recent changes in attitudes toward psychiatric medications in the U.S. general population.
METHODS: Samples of adult participants in the U.S. General Social Surveys of 1998 (N=1,387) and 2006 (N=1,437) were compared for opinions on the benefits and risks of psychiatric medications as well as willingness to take them in hypothetical situations, including experiencing symptoms of panic attacks or major depression and difficulty in coping with stress or having trouble in personal life.
RESULTS: Public opinions regarding benefits of psychiatric medications became more favorable between 1998 and 2006. More participants in 2006 than in 1998 thought that medications help people to deal with day-to-day stresses (83.4% versus 77.8%), make things easier in relation with family and friends (75.9% versus 68.4%), and help people feel better about themselves (68.0% versus 60.1%). The public expressed a greater willingness to take medications in 2006 compared with 1998 for trouble in personal life (29.1% versus 23.3%), to cope with stresses of life (46.6% versus 35.5%), for depression (49.1% versus 41.2%), and for panic attacks (63.7% versus 55.6%). Opinions regarding the risks of medications did not change between 1998 and 2006.
CONCLUSIONS: Americans' opinions toward psychiatric medications became more favorable over the past decade, and people became more willing to take these medications. These changes have likely contributed to the increased use of psychiatric medications in recent years and will continue to do so in the coming years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648187     DOI: 10.1176/ps.2009.60.8.1015

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  16 in total

1.  Racial differences in the availability and use of electroconvulsive therapy for recurrent major depression.

Authors:  Brady G Case; David N Bertollo; Eugene M Laska; Carole E Siegel; Joseph A Wanderling; Mark Olfson
Journal:  J Affect Disord       Date:  2011-12-12       Impact factor: 4.839

2.  Antidepressant Prescribing in Primary Care to Older Adults Without Major Depression.

Authors:  Donovan T Maust; Jo Anne Sirey; Helen C Kales
Journal:  Psychiatr Serv       Date:  2017-01-03       Impact factor: 3.084

3.  Factors Associated with Geographic Variation in Psychiatric Prescription Drug Expenditures Among Medicaid Beneficiaries.

Authors:  Julia Zur; Leighton Ku
Journal:  J Behav Health Serv Res       Date:  2016-07       Impact factor: 1.505

4.  National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care.

Authors:  Donovan T Maust; Frederic C Blow; Ilse R Wiechers; Helen C Kales; Steven C Marcus
Journal:  J Clin Psychiatry       Date:  2017-04       Impact factor: 4.384

5.  Public attitudes towards psychiatric medication: a comparison between United States and Germany.

Authors:  Georg Schomerus; Herbert Matschinger; Sebastian E Baumeister; Ramin Mojtabai; Matthias C Angermeyer
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

6.  Perceived Need for Mental Health Care: The Intersection of Race, Ethnicity, Gender, and Socioeconomic Status.

Authors:  Alice P Villatoro; Vickie M Mays; Ninez A Ponce; Carol S Aneshensel
Journal:  Soc Ment Health       Date:  2017-08-01

7.  Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States.

Authors:  Lauren B Gerlach; Mark Olfson; Helen C Kales; Donovan T Maust
Journal:  J Am Geriatr Soc       Date:  2017-05-03       Impact factor: 5.562

8.  Psychotropic medication treatment of adolescents: results from the National Comorbidity Survey-Adolescent Supplement.

Authors:  Mark Olfson; Jian-Ping He; Kathleen Ries Merikangas
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-03-07       Impact factor: 8.829

Review 9.  Biomedical Explanations of Psychopathology and Their Implications for Attitudes and Beliefs About Mental Disorders.

Authors:  Matthew S Lebowitz; Paul S Appelbaum
Journal:  Annu Rev Clin Psychol       Date:  2018-11-16       Impact factor: 18.561

Review 10.  Public stigma of mental illness in the United States: a systematic literature review.

Authors:  Angela M Parcesepe; Leopoldo J Cabassa
Journal:  Adm Policy Ment Health       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.